Prolocor

About:

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.

Top Investors: LabCorp, Small Business Innovation Research, LabCorp Venture Fund, Green Park & Golf Ventures

Description:

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases. The company's goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease. Prolocor was founded in 2020 and is based in Philadelphia, PA.

Total Funding Amount:

$6.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)prolocor.com

Founders:

David Schneider, Peter M. DiBattiste

Number of Employees:

1-10

Last Funding Date:

2024-02-27

IPO Status:

Private

Industries: